NCT07469761

Brief Summary

The goal of this clinical trial is to learn whether a structured, Patient-Reported Outcome Measures (PROMs)-tailored palliative care pathway improves clinical outcomes and care experience in adults with advanced cancer referred to outpatient palliative care. Patients with advanced cancer often experience multiple symptoms and complex needs. Standard outpatient palliative care is usually guided by clinical judgment on patient-reported questionnaires. In this study, researchers aim to test whether a more structured approach, based on predefined cut-offs from PROMs, can improve symptom control, satisfaction with care, and use of healthcare resources. The main questions the study aims to answer are: Does a structured, PROM-driven palliative care pathway reduce symptom burden and psychological distress compared with usual care? And through this, to improve patients' and caregivers' satisfaction with care or reduce emergency room visits, hospital admissions, healthcare costs, and aggressive treatments near the end of life? Researchers will compare two groups: Control group: Participants will receive standard outpatient palliative care. PROMs are collected as usual, but without predefined cut-offs or structured intervention checklists. Experimental group: Participants will receive a structured palliative care pathway tailored to symptoms/needs identified at baseline using PROM cut-offs. Specific multidisciplinary interventions are activated according to identified needs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Nov 2025Feb 2027

Study Start

First participant enrolled

November 2, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

March 5, 2026

Last Update Submit

March 9, 2026

Conditions

Keywords

Patient Reported Outcome Measurements (PROMs)OutpatientPalliative CareAdvanced cancerFrailtyPalliative Care intervention

Outcome Measures

Primary Outcomes (2)

  • Change in overall symptom burden assessed by the ESAS.

    \- Mean change in symptom burden from baseline to 1 month after initiation of palliative care, measured using the Edmonton Symptom Assessment System (ESAS) total score (range 0-90, higher scores indicating greater symptom burden). The analysis will compare the change in ESAS total score between the two randomized groups.

    1, 3 months

  • Change in psychological distress assessed by the Distress Thermometer (DT).

    Mean change in psychological distress from baseline to 1 month after initiation of palliative care, measured using the Distress Thermometer (DT) (range 0-10, higher scores indicating greater distress). The analysis will compare the change in DT score between the two randomized groups.

    1, 3 Months

Secondary Outcomes (4)

  • Patients' satisfaction with care

    1, 3 months

  • Healthcare resource utilization

    3, 6 months

  • Differeces in End of Life (EoL) care aggressiveness criteria

    3, 6 months

  • Caregivers' satisfaction with care

    1, 3 months

Study Arms (2)

Structured interventions tailored to PROMs cut-off

EXPERIMENTAL

• Experimental group, which will follow a structured palliative care pathway (specific intervention defined in the protocol) based on the frailties identified at baseline PROMs (defined by cut-off).

Other: Structured Palliative Care

Classic Palliative Car interventions

ACTIVE COMPARATOR

• Control group, which will undergo standard unstructured palliative care (based on PROMs as usual, but without cut-off or interventions' checklists)

Other: Classical Palliative Care

Interventions

Symptoms/needs domains are defined according to protocol-specified cut-offs, followed by the activation of a tailored intervention based on structured checklists targeting the reported symptoms/needs.

Structured interventions tailored to PROMs cut-off

Multidisciplinary palliative care interventions are delivered according to usual clinical practice, without activation based on predefined cut-offs or structured algorithms.

Classic Palliative Car interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of advanced/metastatic cancer
  • age \> 18
  • Eastern Cooperative Oncology Group (ECOG) performance status ≥2
  • prognostic clinical prediction \>1 month.

You may not qualify if:

  • Serious medical or psychiatric illness that can interfere with informed consent and participation in this clinical study
  • any condition that is unstable or could jeopardize the safety of the patient and their compliance in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Nazionale dei Tumori, Via Venezian n1

Milan, Lombardy, 20133, Italy

RECRUITING

MeSH Terms

Conditions

FrailtyNeoplasms

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study adopts a pragmatic design, leveraging resources already available within routine palliative care services, while implementing predefined algorithms in which symptom and need thresholds (cut-offs) trigger tailored multidisciplinary interventions. In particular: * Control group, which will undergo standard unstructured palliative care (based on PROMs as usual, but without cut-off or interventions' checklists) * Experimental group, which will follow a structured palliative care pathway (specific intervention defined in the protocol) based on the frailties identified at baseline PROMs (defined by cut-off).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 5, 2026

First Posted

March 13, 2026

Study Start

November 2, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

February 28, 2027

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

De-identified IPD underlying published results, together with the study protocol, statistical analysis plan, and data dictionary, will be shared in line with the FAIR principles and the "as open as possible, as closed as necessary" approach of Horizon Europe. Data management will follow a predefined Data Management Plan and comply with Regulation (EU) 2016/679 (GDPR) and GCP standards. Data will be available from 6 months after publication for at least 5 years through controlled access, subject to a scientifically sound proposal, steering committee approval, and a Data Access Agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The study protocol, statistical analysis plan, and informed consent form template will be made available upon reasonable request following study registration and may be shared prior to publication. De-identified individual participant data underlying the published results, together with a data dictionary, will be made available beginning 6 months after publication of the primary results and for at least 5 years thereafter. Data will be shared through a controlled access process, subject to submission of a methodologically sound proposal, approval by the study steering committee, and execution of a Data Access Agreement, in compliance with GDPR and GCP standards.

Locations